Share on StockTwits

CareFusion (NYSE:CFN) has received an “A-” credit rating from analysts at Morningstar. The firm’s “A-” rating suggests that the company is a low default risk. They also issued a negative credit outlook for the company and gave their stock a three star rating.

A number of other analysts have also recently weighed in on CFN. Analysts at Bank of America reiterated a “buy” rating on shares of CareFusion in a research note on Monday, August 18th. They now have a $43.97 price target on the stock, down previously from $50.00. Separately, analysts at Raymond James reiterated a “strong-buy” rating on shares of CareFusion in a research note on Friday, August 15th. They now have a $52.00 price target on the stock, up previously from $50.00. Finally, analysts at Piper Jaffray raised their price target on shares of CareFusion from $45.00 to $48.00 in a research note on Friday, August 8th. Five analysts have rated the stock with a hold rating, two have given a buy rating and one has assigned a strong buy rating to the stock. CareFusion currently has a consensus rating of “Buy” and an average price target of $45.25.

CareFusion (NYSE:CFN) opened at 46.04 on Thursday. CareFusion has a 1-year low of $35.89 and a 1-year high of $46.52. The stock has a 50-day moving average of $44.43 and a 200-day moving average of $42.26. The company has a market cap of $9.340 billion and a P/E ratio of 23.62.

CareFusion (NYSE:CFN) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.79 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.72 by $0.07. The company had revenue of $1.12 billion for the quarter, compared to the consensus estimate of $1.04 billion. During the same quarter in the prior year, the company posted $0.55 earnings per share. The company’s quarterly revenue was up 24.3% on a year-over-year basis. On average, analysts predict that CareFusion will post $2.68 earnings per share for the current fiscal year.

CareFusion Corporation (NYSE:CFN) is a global medical technology company.

To view more credit ratings from Morningstar, visit www.morningstar.com.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.